Published in Exp Diabetes Res on September 12, 2012
Performance of the estimated glomerular filtration rate creatinine and cystatin C based equations in Thai patients with chronic glomerulonephritis. Int J Nephrol Renovasc Dis (2015) 0.75
Comparison between a serum creatinine-and a cystatin C-based glomerular filtration rate equation in patients receiving amphotericin B. Daru (2016) 0.75
Statistical methods for assessing agreement between two methods of clinical measurement. Lancet (1986) 211.50
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med (2004) 49.19
Assessing kidney function--measured and estimated glomerular filtration rate. N Engl J Med (2006) 20.27
Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis (2008) 15.04
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem (2005) 8.93
Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis (2002) 6.52
Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol (2007) 6.00
Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol (2005) 5.99
Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol (2004) 5.29
Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int (2006) 4.59
Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis (2000) 4.44
Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study. J Am Soc Nephrol (2005) 3.48
Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis (2011) 2.98
First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med (2010) 2.95
A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant (2003) 2.95
A Comparison of GFR estimating formulae based upon s-cystatin C and s-creatinine and a combination of the two. Nephrol Dial Transplant (2007) 2.52
Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest (2004) 2.48
Standardization of Cystatin C: development of primary and secondary reference preparations. Scand J Clin Lab Invest Suppl (2008) 2.11
Serum cystatin C as an endogenous marker of the renal function--a review. Clin Chem Lab Med (1999) 2.05
Report of the Radionuclides in Nephrourology Committee on renal clearance. J Nucl Med (1996) 1.98
Creatinine filtration, secretion and excretion during progressive renal disease. Modification of Diet in Renal Disease (MDRD) Study Group. Kidney Int Suppl (1989) 1.66
Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int (2007) 1.48
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods. Diabetologia (2006) 1.42
Reference range and method comparison studies for enzymatic and Jaffé creatinine assays in plasma and serum and early morning urine. Clin Lab (2000) 1.28
Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant (2006) 1.16
Serum cystatin C-based formulas for prediction of glomerular filtration rate in patients with chronic kidney disease. Nephron Clin Pract (2009) 1.09
Serum cystatin C-based equation compared to serum creatinine-based equations for estimation of glomerular filtration rate in patients with chronic kidney disease. Clin Nephrol (2008) 1.03
Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. Diabetologia (2009) 0.99
Cystatin C for early detection of renal impairment in diabetes. Clin Biochem (2008) 0.97
Cystatin C improves the diagnosis and stratification of chronic kidney disease, and the estimation of glomerular filtration rate in diabetes. Diabetes Metab (2008) 0.95
Serum cystatin C as an endogenous marker of renal function in the elderly. Int J Clin Pharmacol Res (2004) 0.95
Influence of body weight on the performance of glomerular filtration rate estimators in subjects with type 2 diabetes. Diabetes Care (2007) 0.88
Weight loss and mortality in type 2 diabetes. Diabetes Care (2000) 0.83
[Evaluation of the renal function in type 2 diabetes: clearance calculation or cystatin C?]. Ann Biol Clin (Paris) (2012) 0.79
A simplified Cockcroft-Gault formula to improve the prediction of the glomerular filtration rate in diabetic patients. Diabetes Metab (2006) 0.77
Monitoring renal function in obese patients with type 2 diabetes mellitus in daily practice. Diabetes Nutr Metab (2001) 0.77
A prospective study about impact of renal dysfunction and morbidity and mortality on cardiovascular events after ischemic stroke. Cardiol J (2013) 1.97
Ankle-brachial index and cardiovascular mortality in nondiabetic hemodialysis patients. Ther Apher Dial (2013) 1.97
A new serum cystatin C formula for estimating glomerular filtration rate in newborns. Pediatr Nephrol (2015) 1.49
Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function. Nephrol Dial Transplant (2006) 1.16
Serum cystatin C-based formulas for prediction of glomerular filtration rate in patients with chronic kidney disease. Nephron Clin Pract (2009) 1.09
Predictive value of carotid intima media thickness in hemodialysis patients. Artif Organs (2005) 0.99
Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients. Ther Apher Dial (2009) 0.95
Simple cystatin C formula compared to sophisticated CKD-EPI formulas for estimation of glomerular filtration rate in the elderly. Ther Apher Dial (2011) 0.94
Cystatin C versus creatinine as a marker of glomerular filtration rate in the newborn. Wien Klin Wochenschr (2006) 0.85
Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease. Ren Fail (2008) 0.84
Mortality of patients with renal dysfunction after percutaneous coronary intervention. Angiology (2009) 0.83
Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease. Ther Apher Dial (2013) 0.82
Biomarkers in hemodialysis patients. Adv Clin Chem (2012) 0.81
Serum cystatin-C as a marker of acute kidney injury in the newborn after perinatal hypoxia/asphyxia. Ther Apher Dial (2013) 0.81
Atherosclerosis in hemodialysis patients--the role of microinflammation. Ren Fail (2008) 0.80
Paricalcitol reduces proteinuria in non-dialysis chronic kidney disease patients. Ther Apher Dial (2013) 0.79
Radiographic assessment of vascular calcification, aortic pulse wave velocity, ankle-brachial index and fibroblast growth factor-23 in chronic hemodialysis patients. Ther Apher Dial (2013) 0.79
Homocysteine and vascular access thrombosis in hemodialysis patients. Ren Fail (2002) 0.79
Blood pressure measurements and carotid intima media thickness in hemodialysis patients. Ther Apher Dial (2009) 0.79
Markers of Inflammation and Oxidative Stress in the Development and Progression of Renal Disease in Diabetic Patients. Nephron (2016) 0.78
Ascorbic Acid for the prevention of contrast-induced nephropathy after coronary angiography in patients with chronic renal impairment: a randomized controlled trial. Ther Apher Dial (2013) 0.78
Investigation of unusual high serum indices for lipemia in clear serum samples on siemens analysers dimension. Biochem Med (Zagreb) (2012) 0.77
PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease. BMC Med Genet (2006) 0.77
An accident with Tenckhoff catheter placement: urinary bladder perforation. Nephrol Dial Transplant (2006) 0.77
Prognostic value of 48-hour ambulatory blood pressure measurement and cardiovascular mortality in hemodialysis patients. Kidney Blood Press Res (2012) 0.77
Epoetin responsiveness in peritoneal dialysis patients: a multi-center Slovenian study. Ther Apher Dial (2005) 0.77
Fetuin-A as a risk factor for mortality in hemodialysis patients. Wien Klin Wochenschr (2010) 0.77
Acquired cystic kidney disease and arterial hypertension in hemodialysis patients. Wien Klin Wochenschr (2006) 0.77
Asymptomatic atherosclerosis and hypertension in nondiabetic patients with chronic kidney disease. Artif Organs (2008) 0.77
Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients. Ren Fail (2013) 0.76
Antiphospholipid antibodies as a possible risk factor for atherosclerosis in patients with rheumatoid arthritis. Immunobiology (2006) 0.76
Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients. Ther Apher Dial (2013) 0.76
Polyneuropathy in hemodialysis patients: the most sensitive electrophysiological parameters and dialysis adequacy. Wien Klin Wochenschr (2006) 0.76
Antiphospholipid antibodies and atherosclerosis: insights from rheumatoid arthritis--a five-year follow-up study. Immunobiology (2011) 0.76
Measurement of breath ammonia for detection of patients with chronic kidney disease. Clin Nephrol (2017) 0.76
Cardiac troponin T (cTnT) in hemodialysis patients with asymptomatic and symptomatic atherosclerosis. Arch Med Res (2005) 0.75
Gangrenous appendicitis presenting as acute abdominal pain in a patient on automated peritoneal dialysis: a case report. J Med Case Rep (2012) 0.75
Reply to letter to the editor. Ther Apher Dial (2014) 0.75
Authors' response. Cardiol J (2015) 0.75
4. Kidneys and Autoimmune Disease. EJIFCC (2009) 0.75
Testosterone and hemoglobin in hemodialysis male and female patients. Artif Organs (2013) 0.75
Blood pressure measurements and left ventricular mass index in hemodialysis patients. Artif Organs (2012) 0.75
Impact of short-term nutritional supplementation on surrogate markers of undernutrition in hemodialysis patients - prospective real-life interventional study. Clin Nephrol (2017) 0.75
Very old patients on hemodialysis: how they start and can we predict survival? Blood Purif (2014) 0.75
Hyperuricemia and long-term survival in patients with chronic kidney disease undergoing hemodialysis. Clin Nephrol (2017) 0.75
Simple cystatin C formula compared to serum creatinine-based formulas for estimation of glomerular filtration rate in patients with mildly to moderately impaired kidney function. Kidney Blood Press Res (2012) 0.75
Non-insertion-related complications of central venous catheterization--temporary vascular access for hemodialysis. Ren Fail (2007) 0.75
Renal replacement therapy in Slovenia: excerpts from 2011 data. Ther Apher Dial (2013) 0.75
Albuminuria is Associated With Subendocardial Viability Ratio in Chronic Kidney Disease Patients. Kidney Blood Press Res (2015) 0.75
Forty-eight-hour ambulatory blood pressure and carotid-femoral pulse wave velocity in hemodialysis patients. Ther Apher Dial (2011) 0.75
[Comparison of the intact PTH test with the total PTH test in hemodialyzed patients]. Acta Med Croatica (2003) 0.75
Relationship between subendocardial viability ratio and hemoglobin in patients with chronic kidney disease. Clin Nephrol (2017) 0.75
[Sterile peritonitis after administration of icodextrin]. Acta Med Croatica (2002) 0.75
Effect of cholecystectomy for gallstones on the surface of the papilla of Vater and the diameter of the common bile duct. Eur J Gastroenterol Hepatol (2002) 0.75
Rare manifestation of the thrombotic microangiopathy in a patient with sarcoidosis, common variable immunodeficiency and large B-cell non-hodgkin lymphoma: case report. Transfus Apher Sci (2013) 0.75
Atherosclerosis in hemodialysis patients: traditional and nontraditional risk factors. Acta Dermatovenerol Alp Pannonica Adriat (2006) 0.75